Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNOT7 | Q9UIV1 | 10/20 | 0.53 |
| ▸ | CASR | P41180 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | PARN | O95453 | 1/20 | 0.39 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7992307 | 0.94 | CNOT7 (0.54) | CNOT7CASRPTPN1PARNCXCR2 | |
| SCHEMBL7985342 | 0.89 | CNOT7 (0.51) | CNOT7ALDH1A1PTPN1PARNCXCR2 | |
| SCHEMBL7974620 | 0.89 | CNOT7 (0.58) | CNOT7ALDH1A1PARNKDM4ELMNA | |
| SCHEMBL7984686 | 0.88 | CNOT7 (0.50) | CNOT7ALDH1A1PARNKDM4ELMNA | |
| SCHEMBL7988586 | 0.88 | CNOT7 (0.50) | CNOT7ALDH1A1PARNKDM4ELMNA | |
| SCHEMBL7988553 | 0.88 | CNOT7 (0.50) | CNOT7ALDH1A1PARNCXCR2 | |
| SCHEMBL7989011 | 0.85 | KDM4E (0.48) | CNOT7ALDH1A1KDM4ELMNAMAPK1 | |
| SCHEMBL7984403 | 0.83 | CNOT7 (0.47) | CNOT7CASRALDH1A1PTPN1DAO | |
| SCHEMBL7991681 | 0.83 | CNOT7 (0.54) | CNOT7ALDH1A1PARNCXCR2KDM4E | |
| SCHEMBL7984244 | 0.82 | CNOT7 (0.60) | CNOT7ALDH1A1PARNDAOKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6310070-B1 | FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS | JAPAN ENERGY CORPORATION (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-0999211-A1 | NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF | JAPAN ENERGY CORPORATION (JP) | 2000-05-10 | — | — | EP | disclosed |